# US 2019/0244677 A1 · Systems, Methods, and Gene Signatures for Predicting the Biological Status of an Individual

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0244677 A1
- Document ID: US20190244677A1
- Status: Published application
- Kind: A1
- Application number: 16/333,157
- Filed: 2017-05-30
- Published: 2019-08-08
- Earliest claimed: 2016-09-14
- Assignees: Philip Morris Products S.A.
- Applicants: Philip Morris Products S.A.
- Inventors: Carine POUSSIN; Vincenzo BELCASTRO; Florian MARTIN; Stephanie BOUE; Manuel Claude PEITSCH
- Web page: https://patentgrep.com/patent/US20190244677A1

## CPC

- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16H 70/60: relating to pathologies
- C12Q 2600/158: Expression markers
- G16B 40/20: Supervised data analysis
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Systems and methods for assessing a subject's sample to predict the subject's biological status, such as a smoker status. The computer-implemented method includes receiving, by a computer system including at least one hardware processor, a data set associated with the sample. The data set comprises quantitative expression data for a set of genes less than a whole genome, the set of genes comprising AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, and TLR5. The at least one hardware processor generates a score based on the quantitative expression data for the set of genes in the received data set, wherein the score is based on fewer than 40 genes and is indicative of a predicted smoking status of the subject.

## Claims

### Claim 1

A computer-implemented method for assessing a sample obtained from a subject, comprising:
receiving, by a computer system including at least one hardware processor a data set associated with the sample, the data set comprising quantitative expression data for a set of genes less than a whole genome, the set of genes comprising AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, and TLR5; and
generating, by the at least one hardware processor, a score based on the quantitative expression data for the set of genes in the received data set, wherein the score is based on fewer than 40 genes and is indicative of a predicted smoking status of the subject.

### Claim 2 (depends on 1)

The computer-implemented method of claim 1, wherein the set of genes further comprises AK8, FSTL1, RGL1, and VSIG4.

### Claim 3 (depends on 1)

The computer-implemented method of claim 1, wherein the set of genes further comprises C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, and PTGFRN.

### Claim 4 (depends on 1)

The computer-implemented method of claim 1, wherein the score is a result of a classification scheme applied to the data set, wherein the classification scheme is determined based on the quantitative expression data in the data set.

### Claim 5 (depends on 1)

The computer-implemented method of claim 1, further comprising computing a fold-change value for each of AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, and TLR5.

### Claim 6 (depends on 5)

The computer-implemented method of claim 5, further comprising determining that each fold-change value satisfies at least one criterion that requires that each respective computed fold-change value exceeds a predetermined threshold for at least two independent population data sets.

### Claim 7 (depends on 1)

The computer-implemented method of claim 1, wherein the set of genes consists of AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, and TLR5.

### Claim 8 (depends on 1)

A non-transitory computer-readable medium having instructions stored thereon that, when executed by at least one computing device, cause the at least one computing device to perform operations comprising the method of claim 1.

### Claim 9

A kit for predicting smoker status of an individual, comprising:
a set of reagents that detects expression levels of the genes in a gene signature having fewer than 40 genes, the gene signature comprising AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, and TLR5 in a test sample; and
instructions for using said kit for predicting smoker status in the individual.

### Claim 10 (depends on 9)

The kit of claim 9, wherein the kit is used for assessing an effect of an alternative to a smoking product on an individual.

### Claim 11 (depends on 10)

The kit of claim 10, wherein the alternative to the smoking product is a heated tobacco product.

### Claim 12 (depends on 9)

The kit of claim 9, wherein the effect of the alternative on the individual is to classify the individual as a non-smoker.

### Claim 13 (depends on 9)

The kit of claim 9, wherein the gene signature further comprises AK8, FSTL1, RGL1, and VSIG4.

### Claim 14 (depends on 9)

The kit of claim 9, wherein the gene signature further comprises C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, and PTGFRN.

### Claim 15

A computer-implemented method for assessing a sample obtained from a subject, comprising:
receiving, by a computer system including at least one hardware processor, a data set associated with the sample, the data set comprising quantitative expression data for a set of genes less than a whole genome, the set of genes comprising LRRN3, AHHR, CDKN1C, PID1, SASH1, GPR15, LINC00599, P2RY6, CLEC10A, SEMA6B, F2R, CTTNBP2, and GPR63; and
generating, by the at least one hardware processor, a score based on the quantitative expression data for the set of genes in the received data set, wherein the score is based on fewer than 40 genes and is indicative of a predicted smoking status of the subject.

### Claim 16 (depends on 15)

The computer-implemented method of claim 15, wherein the score is a result of a classification scheme applied to the data set, wherein the classification scheme is determined based on the quantitative expression data in the data set.

### Claim 17 (depends on 15)

The computer-implemented method of claim 15, further comprising computing a fold-change value for each of LRRN3, AHHR, CDKN1C, PID1, SASH1, GPR15, LINC00599, P2RY6, CLEC10A, SEMA6B, F2R, CTTNBP2, and GPR63.

### Claim 18 (depends on 17)

The computer-implemented method of claim 17, further comprising determining that each fold-change value satisfies at least one criterion that requires that each respective computed fold-change value exceeds a predetermined threshold for at least two independent population data sets.

### Claim 19 (depends on 15)

The computer-implemented method of claim 15, wherein the set of genes consists of LRRN3, AHHR, CDKN1C, PID1, SASH1, GPR15, LINC00599, P2RY6, CLEC10A, SEMA6B, F2R, CTTNBP2, and GPR63.

### Claim 20 (depends on 15)

A non-transitory computer-readable medium having instructions stored thereon that, when executed by at least one computing device, cause the at least one computing device to perform operations comprising the method of claim 15.

### Claim 21

A kit for predicting smoker status of an individual, comprising:
a set of reagents that detects expression levels of the genes in a gene signature having fewer than 40 genes, the gene signature comprising LRRN3, AHHR, CDKN1C, PID1, SASH1, GPR15, LINC00599, P2RY6, CLEC10A, SEMA6B, F2R, CTTNBP2, and GPR63 in a test sample; and
instructions for using said kit for predicting smoker status in the individual.

### Claim 22 (depends on 21)

The kit of claim 21, wherein the kit is used for assessing an effect of an alternative to a smoking product on an individual.

### Claim 23 (depends on 22)

The kit of claim 22, wherein the alternative to the smoking product is a heated tobacco product.

### Claim 24 (depends on 21)

The kit of claim 21, wherein the effect of the alternative on the individual is to classify the individual as a non-smoker.

### Claim at position 25

25-45. (canceled)

### Claim 46

A computer-implemented method for assessing a sample obtained from a subject, comprising:
receiving, by a computer system including at least one hardware processor, a data set associated with the sample, the data set comprising quantitative expression data for a set of genes less than a whole genome, the set of genes comprising AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, TLR5, AK8, FSTL1, RGL1, VSIG4, C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, PTGFRN, ASGR2, B3GALT2, CYP4F22, FUCA1, GPR63, GUCY1B3, MB21D2, NLK, NR4A1, P2RY1, PF4, PTGFR, SH2D1B, ST6GALNAC1, TMEM163, TPPP3, and ZNF618; and
generating, by the at least one hardware processor, a score based on the received data set, wherein the score is indicative of a predicted smoking status of the subject.

### Claim 47 (depends on 46)

The computer-implemented method of claim 46, wherein the score is a result of a classification scheme applied to the data set, wherein the classification scheme is determined based on the quantitative expression data in the data set.

### Claim 48 (depends on 46)

The computer-implemented method of claim 46, further comprising computing a fold-change value for each of AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, TLR5, AK8, FSTL1, RGL1, VSIG4, C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, PTGFRN, ASGR2, B3GALT2, CYP4F22, FUCA1, GPR63, GUCY1B3, MB21D2, NLK, NR4A1, P2RY1, PF4, PTGFR, SH2D1B, ST6GALNAC1, TMEM163, TPPP3, and ZNF618.

### Claim 49 (depends on 48)

The computer-implemented method of claim 48, further comprising determining that each fold-change value satisfies at least one criterion that requires that each respective computed fold-change value exceeds a predetermined threshold for at least two independent population data sets.

### Claim 50 (depends on 46)

The computer-implemented method of claim 46, wherein the set of genes consists of AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, TLR5, AK8, FSTL1, RGL1, VSIG4, C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, PTGFRN, ASGR2, B3GALT2, CYP4F22, FUCA1, GPR63, GUCY1B3, MB21D2, NLK, NR4A1, P2RY1, PF4, PTGFR, SH2D1B, ST6GALNAC1, TMEM163, TPPP3, and ZNF618.

### Claim 51 (depends on 46)

A non-transitory computer-readable medium having instructions stored thereon that, when executed by at least one computing device, causes the at least one computing device to perform operations comprising the method of claim 46.

### Claim 52

A kit for predicting smoker status of an individual, comprising:
a set of reagents that detects expression levels of the genes in a gene signature in a test sample, the gene signature comprising AHHR, CDKN1C, LRRN3, PID1, GPR15, SASH1, CLEC10A, LINC00599, P2RY6, DSC2, F2R, SEMA6B, TLR5, AK8, FSTL1, RGL1, VSIG4, C15orf54, CTTNBP2, RANK1, GSE1, GUCY1A3, LOC200772, MARC2, MIR4697HG, PTGFRN, ASGR2, B3GALT2, CYP4F22, FUCA1, GPR63, GUCY1B3, MB21D2, NLK, NR4A1, P2RY1, PF4, PTGFR, SH2D1B, ST6GALNAC1, TMEM163, TPPP3, and ZNF618; and
instructions for using said kit for predicting smoker status in the individual.

### Claim 53 (depends on 52)

The kit of claim 52, wherein the kit is used for assessing an effect of an alternative to a smoking product on an individual.

### Claim 54 (depends on 53)

The kit of claim 53, wherein the alternative to the smoking product is a heated tobacco product.

### Claim 55 (depends on 52)

The kit of claim 52, wherein the effect of the alternative on the individual is to classify the individual as a non-smoker.

### Claim 56

A computer-implemented method for assessing a sample obtained from a subject, comprising:
receiving, by a computer system including at least one hardware processor, a data set associated with the sample, the data set comprising quantitative expression data for a set of genes less than a whole genome, the set of genes comprising AHHR, P2RY6, KLRG1, LRRN3, COX6B2, CTTNBP2, DSC2, F2R, GUCY1B3, MT2, NGFRAP1, REEP6, SASH1, and TBX21; and
generating, by the at least one hardware processor, a score based on the quantitative expression data for the set of genes in the received data set, wherein the score is based on fewer than 40 genes and is indicative of a predicted smoking status of the subject.

### Claim 57 (depends on 56)

The computer-implemented method of claim 56, wherein the score is a result of a classification scheme applied to the data set, wherein the classification scheme is determined based on the quantitative expression data in the data set.

### Claim 58 (depends on 56)

The computer-implemented method of claim 56, further comprising computing a fold-change value for each of AHHR, P2RY6, KLRG1, LRRN3, COX6B2, CTTNBP2, DSC2, F2R, GUCY1B3, MT2, NGFRAP1, REEP6, SASH1, and TBX21.

### Claim 59 (depends on 58)

The computer-implemented method of claim 58, further comprising determining that each fold-change value satisfies at least one criterion that requires that each respective computed fold-change value exceeds a predetermined threshold for at least two independent population data sets.

### Claim 60 (depends on 56)

The computer-implemented method of claim 56, wherein the set of genes consists of AHHR, P2RY6, KLRG1, LRRN3, COX6B2, CTTNBP2, DSC2, F2R, GUCY1B3, MT2, NGFRAP1, REEP6, SASH1, and TBX21.

### Claim 61 (depends on 56)

A non-transitory computer-readable medium having instructions stored thereon that, when executed by at least one computing device, causes the at least one computing device to perform operations comprising the method of claim 56.

### Claim 62

A kit for predicting smoker status of an individual, comprising:
a set of reagents that detects expression levels of the genes in a gene signature in a test sample, the gene signature comprising AHHR, P2RY6, KLRG1, LRRN3, COX6B2, CTTNBP2, DSC2, F2R, GUCY1B3, MT2, NGFRAP1, REEP6, SASH1, and TBX21, the gene signature comprising fewer than 40 genes; and
instructions for using said kit for predicting smoker status in the individual.

### Claim 63 (depends on 62)

The kit of claim 62, wherein the kit is used for assessing an effect of an alternative to a smoking product on an individual.

### Claim 64 (depends on 63)

The kit of claim 63, wherein the alternative to the smoking product is a heated tobacco product.

### Claim 65 (depends on 63)

The kit of claim 63, wherein the effect of the alternative on the individual is to classify the individual as a non-smoker.
